Anebulo Pharmaceuticals (ANEB) Accumulated Expenses (2020 - 2025)
Anebulo Pharmaceuticals' Accumulated Expenses came in at $930,784 for fiscal Q2 2026 (quarter ended Dec 31, 2025), up 66.4% from $559,284 a year earlier and up 161.2% from the prior quarter.
Powered by 
Analysis
Anebulo Pharmaceuticals (ANEB) Accumulated Expenses (2020 - 2025) Analysis & Trends
At the end of FY2025 (ended Jun 30, 2025), Anebulo Pharmaceuticals' Accumulated Expenses was $263,513, up 153.0% from FY2024.
- Accumulated Expenses carries a five-year compound annual growth rate of 63.5% (FY2020 to FY2025).
- Going back by fiscal year, Accumulated Expenses was $104,157 in FY2024 (-80.5%), $534,256 in FY2023 (+305.7%), $131,703 in FY2022 (+0.1%) and $131,585 in FY2021 (+482.8%).
- The fiscal Q2 2026 figure represents the highest quarterly Accumulated Expenses since fiscal Q2 2023.
- Year-over-year, Accumulated Expenses has increased for three consecutive quarters, with growth averaging 16.2% over the last eight quarters.
- The fastest year-over-year change in Accumulated Expenses over five years came in fiscal Q4 2021 (growth of 482.8%), and the weakest in fiscal Q3 2022 (a decline of 98.8%).
- Business Quant data shows ANEB's Accumulated Expenses at $356,282 (Q1 2026), $263,513 (Q4 2025) and $118,454 (Q3 2025) in the three fiscal quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Anebulo Pharmaceuticals | 11.91 Mn | -32.39 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 930,784.00 |
| Sep 30, 2025 | 356,282.00 |
| Jun 30, 2025 | 263,513.00 |
| Mar 31, 2025 | 118,454.00 |
| Dec 31, 2024 | 559,284.00 |
| Sep 30, 2024 | 317,083.00 |
| Jun 30, 2024 | 104,157.00 |
| Mar 31, 2024 | 625,401.00 |
| Dec 31, 2023 | 694,877.00 |
| Sep 30, 2023 | 150,611.00 |
| Jun 30, 2023 | 534,256.00 |
| Mar 31, 2023 | 920,183.00 |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 174,706.00 |
| Jun 30, 2022 | 131,703.00 |
| Mar 31, 2022 | 2,500.00 |
| Dec 31, 2021 | 7,000.00 |
| Sep 30, 2021 | 113,887.00 |
| Jun 30, 2021 | 131,585.00 |
| Mar 31, 2021 | 211,139.00 |
API Access
Anebulo Pharmaceuticals Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "ANEB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=ANEB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();